Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: E9AVB3
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0016192 | vesicle-mediated transport | 4 | 12 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 97 | 101 | PF00656 | 0.590 |
CLV_NRD_NRD_1 | 242 | 244 | PF00675 | 0.563 |
CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.390 |
CLV_PCSK_KEX2_1 | 244 | 246 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.390 |
CLV_PCSK_PC1ET2_1 | 244 | 246 | PF00082 | 0.591 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.336 |
DOC_MAPK_gen_1 | 154 | 162 | PF00069 | 0.536 |
DOC_MAPK_MEF2A_6 | 154 | 162 | PF00069 | 0.560 |
DOC_PP4_FxxP_1 | 116 | 119 | PF00568 | 0.661 |
DOC_PP4_FxxP_1 | 131 | 134 | PF00568 | 0.498 |
DOC_PP4_FxxP_1 | 37 | 40 | PF00568 | 0.595 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.705 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.644 |
LIG_14-3-3_CanoR_1 | 50 | 54 | PF00244 | 0.593 |
LIG_14-3-3_CanoR_1 | 57 | 64 | PF00244 | 0.560 |
LIG_BRCT_BRCA1_1 | 58 | 62 | PF00533 | 0.484 |
LIG_CaM_IQ_9 | 197 | 212 | PF13499 | 0.494 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.504 |
LIG_FHA_1 | 80 | 86 | PF00498 | 0.446 |
LIG_Integrin_isoDGR_2 | 241 | 243 | PF01839 | 0.552 |
LIG_LIR_Apic_2 | 129 | 134 | PF02991 | 0.576 |
LIG_LIR_Apic_2 | 34 | 40 | PF02991 | 0.600 |
LIG_LIR_Gen_1 | 42 | 48 | PF02991 | 0.561 |
LIG_LIR_Gen_1 | 7 | 17 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 75 | 86 | PF02991 | 0.547 |
LIG_LIR_Nem_3 | 42 | 47 | PF02991 | 0.563 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.580 |
LIG_LIR_Nem_3 | 7 | 12 | PF02991 | 0.516 |
LIG_MLH1_MIPbox_1 | 58 | 62 | PF16413 | 0.484 |
LIG_PCNA_yPIPBox_3 | 124 | 136 | PF02747 | 0.621 |
LIG_Pex14_2 | 112 | 116 | PF04695 | 0.552 |
LIG_PTAP_UEV_1 | 29 | 34 | PF05743 | 0.541 |
LIG_SH2_CRK | 13 | 17 | PF00017 | 0.522 |
LIG_SH2_CRK | 88 | 92 | PF00017 | 0.595 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.427 |
LIG_SH3_3 | 114 | 120 | PF00018 | 0.669 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.605 |
LIG_TRAF2_1 | 70 | 73 | PF00917 | 0.710 |
LIG_WRC_WIRS_1 | 234 | 239 | PF05994 | 0.474 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.714 |
MOD_CK1_1 | 31 | 37 | PF00069 | 0.545 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.477 |
MOD_Cter_Amidation | 241 | 244 | PF01082 | 0.518 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.530 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.620 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.738 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.418 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.512 |
MOD_GlcNHglycan | 58 | 61 | PF01048 | 0.503 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.488 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.501 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.590 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.337 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.371 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.429 |
MOD_NEK2_2 | 212 | 217 | PF00069 | 0.368 |
MOD_PIKK_1 | 247 | 253 | PF00454 | 0.700 |
MOD_PK_1 | 244 | 250 | PF00069 | 0.483 |
MOD_PKA_1 | 244 | 250 | PF00069 | 0.535 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.371 |
MOD_PKA_2 | 244 | 250 | PF00069 | 0.483 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.462 |
MOD_PKA_2 | 56 | 62 | PF00069 | 0.405 |
MOD_Plk_1 | 72 | 78 | PF00069 | 0.552 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.548 |
MOD_SUMO_rev_2 | 150 | 156 | PF00179 | 0.348 |
MOD_SUMO_rev_2 | 163 | 168 | PF00179 | 0.492 |
TRG_DiLeu_BaEn_4 | 7 | 13 | PF01217 | 0.575 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.376 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.427 |
TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.406 |
TRG_ENDOCYTIC_2 | 88 | 91 | PF00928 | 0.393 |
TRG_NES_CRM1_1 | 106 | 118 | PF08389 | 0.557 |
TRG_Pf-PMV_PEXEL_1 | 205 | 210 | PF00026 | 0.333 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P366 | Leptomonas seymouri | 77% | 97% |
A0A0S4JL59 | Bodo saltans | 45% | 100% |
A0A1X0NYJ8 | Trypanosomatidae | 57% | 100% |
A0A3Q8IE03 | Leishmania donovani | 95% | 100% |
A0A422NSS3 | Trypanosoma rangeli | 58% | 100% |
A4HBY4 | Leishmania braziliensis | 86% | 100% |
A4HZC6 | Leishmania infantum | 95% | 100% |
D0A159 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
Q4QC67 | Leishmania major | 92% | 100% |
V5BHA3 | Trypanosoma cruzi | 57% | 100% |